{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T17:40:04Z","timestamp":1761154804638},"reference-count":57,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gyn\u00e9cologie Obst\u00e9trique & Fertilit\u00e9"],"published-print":{"date-parts":[[2005,9]]},"DOI":"10.1016\/j.gyobfe.2005.06.011","type":"journal-article","created":{"date-parts":[[2005,8,30]],"date-time":"2005-08-30T11:59:55Z","timestamp":1125403195000},"page":"703-712","source":"Crossref","is-referenced-by-count":2,"title":["Le coasting et les protocoles de stimulation chez les hyperr\u00e9pondeuses en AMP"],"prefix":"10.1016","volume":"33","author":[{"given":"P.","family":"Merviel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Claeys","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.-H.","family":"H\u00e9raud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Lourdel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Lanta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Barbier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Nasreddine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gyobfe.2005.06.011_bib1","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0015-0282(16)53348-2","article-title":"Severe ovarian hyperstimulation syndrome using agonists of gonadotropin-releasing hormone for in vitro fertilization: a European series and a proposal for prevention","volume":"53","author":"Forman","year":"1990","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.gyobfe.2005.06.011_bib2","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/j.1471-0528.1995.tb10840.x","article-title":"Diagnosis, prevention and management of ovarian hyperstimulation syndrome","volume":"102","author":"Brindsen","year":"1995","journal-title":"Br. J. Obstet. Gynaecol."},{"key":"10.1016\/j.gyobfe.2005.06.011_bib3","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/BF01239223","article-title":"The significance of 17 b\u00eata-oestradiol levels in highly responding women during ovulation induction in IVF treatment, its impact and prognostic value with respect to oocyte maturation and treatment outcome","volume":"10","author":"Ben Num","year":"1993","journal-title":"J. Assist. Reprod. Genet."},{"key":"10.1016\/j.gyobfe.2005.06.011_bib4","first-page":"1009","article-title":"Eliminating the riskof life-endangering complications following overstimulation with menotropin fertility agents: a report on women undergoing in vitro fertilization and embryo transfer","volume":"81","author":"Sher","year":"1993","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.gyobfe.2005.06.011_bib5","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1093\/humupd\/3.4.359","article-title":"Modern use of clomiphene citrate in induction of ovulation","volume":"3","author":"Kousta","year":"1997","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.gyobfe.2005.06.011_bib6","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0029-7844(96)00190-1","article-title":"Induction of ovulation in clomiphene-resistant polycystic ovary syndrome with pulsatile GnRH","volume":"88","author":"Tan","year":"1996","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.gyobfe.2005.06.011_bib7","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1210\/jc.79.4.1215","article-title":"Treatment of anovulation with pulsatile gonadotropin-releasing hormone: prognostic factors and clinical results in 600 cycles","volume":"79","author":"Filicori","year":"1994","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.gyobfe.2005.06.011_bib8","series-title":"Symposium Pulsatile GnRH","article-title":"Treatment of anovulation by hMG or GnRH: contribution of a cross-over randomized study to a rational management of PCO","author":"Bringer","year":"1985"},{"key":"10.1016\/j.gyobfe.2005.06.011_bib9","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0015-0282(97)80069-6","article-title":"Early prediction of ovarian multifollicular response during ovulation induction in patients with polycystic ovary syndrome","volume":"67","author":"Farhi","year":"1997","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.gyobfe.2005.06.011_bib10","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/BF02066607","article-title":"The safety and effectiveness of stepwise and low-dose administration of follicle stimulating hormone in WHO group II anovulatory infertile women: Evidence from a large multicenter study in Spain","volume":"13","author":"Balasch","year":"1996","journal-title":"J. Assist. Reprod. Genet."},{"key":"10.1016\/j.gyobfe.2005.06.011_bib11","series-title":"Bailli\u00e8re's Clinical Obstetrics and Gynaecology, 7","article-title":"The step-down principle in gonadotrophin treatment and the role of GnRH analogs","author":"Fauser","year":"1993"},{"key":"10.1016\/j.gyobfe.2005.06.011_bib12","doi-asserted-by":"crossref","first-page":"3821","DOI":"10.1210\/jc.81.11.3821","article-title":"Induction of ovulation with low-dose gonadotropins in polycystic ovary syndrome: an analysis of 109 pregnancies in 225 women","volume":"81","author":"White","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.gyobfe.2005.06.011_bib13","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1111\/j.1471-0528.2003.02290.x","article-title":"Ovulation induction with a starting dose of 50 IU of recombinant follicle stimulating hormone in WHO group II anovulatory women: the IO-50 study, a prospective, observational, multicentre, open trial","volume":"110","author":"Calaf Alsina","year":"2003","journal-title":"Br. J. Obstet. Gynaecol."},{"key":"10.1016\/j.gyobfe.2005.06.011_bib14","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1093\/humrep\/deg336","article-title":"Recombinant FSH Study Group. A comparative randomized multicentric study comparing the step-up versus step-down protocol in polycystic ovary syndrome","volume":"18","author":"Christin-Ma\u00eetre","year":"2003","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.gyobfe.2005.06.011_bib15","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/oxfordjournals.humrep.a138029","article-title":"A controlled study comparing patients with and without polycystic ovaries undergoing in vitro fertilization","volume":"8","author":"Mc Dougall","year":"1993","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.gyobfe.2005.06.011_bib16","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/humrep\/14.1.167","article-title":"The outcome of in vitro fertilization treatment in women with sonographic evidence of polycystic ovarian morphology","volume":"14","author":"Engmann","year":"1999","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.gyobfe.2005.06.011_bib17","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1023\/A:1020593003417","article-title":"Pregnancy rate in IVF rescue in high responders to human menopausal gonadotropin","volume":"16","author":"Many","year":"1999","journal-title":"J. Assist. Reprod. Genet."},{"key":"10.1016\/j.gyobfe.2005.06.011_bib18","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002121","article-title":"Recombinant FSH versus urinary gonadotrophins for ovulation induction in subfertility associated with polycystic ovary syndrome","volume":"2","author":"Bayram","year":"2001","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.gyobfe.2005.06.011_bib19","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0301-2115(00)00309-2","article-title":"Limited ovarian stimulation prevents the recurrence of severe forms of ovarian hyperstimulation syndrome in polycystic ovarian disease","volume":"94","author":"El-Sheikh","year":"2001","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.gyobfe.2005.06.011_bib20","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/S0015-0282(16)56287-6","article-title":"In vitro fertilization and embryo transfer for the treatment of infertility associated with polycystic ovary syndrome","volume":"60","author":"Homburg","year":"1993","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.gyobfe.2005.06.011_bib21","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/S0015-0282(01)01788-5","article-title":"A low-dose stimulation protocol using highly purified follicle-stimulating hormone can lead to high pregnancy rates in in vitro fertilization patients with polycystic ovaries who are at risk of a high ovarian response to gonadotropins","volume":"75","author":"Marci","year":"2001","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.gyobfe.2005.06.011_bib22","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1093\/humrep\/12.11.2359","article-title":"Dual suppression with oral contraceptives and gonadotrophin releasing-hormone agonists improves in-vitro fertilization outcome in high responder patients","volume":"12","author":"Damario","year":"1997","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.gyobfe.2005.06.011_bib23","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1093\/humrep\/13.3.573","article-title":"High dose gonadotrophin-releasing hormone antagonist (ganirelix) may prevent ovarian hyperstimulation syndrome caused by ovarian stimulation for in vitro fertilization","volume":"13","author":"De Jong","year":"1998","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.gyobfe.2005.06.011_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001750","article-title":"Gonadotrophin-releasing hormone antagonists for assisted conception","volume":"4","author":"Al-Inany","year":"2001","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.gyobfe.2005.06.011_bib25","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S1472-6483(10)62163-3","article-title":"Cetrotide International Study Group. Safety and efficacy of a 3 mg dose of GnRH antagonist cetrorelix in preventing premature LH surges: report of two large multicentre, multinational, phase IIIb clinical experiences","volume":"6","author":"Olivennes","year":"2003","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.gyobfe.2005.06.011_bib26","first-page":"373","article-title":"GnRH antagonist in in vitro fertilization: wher we are now","volume":"55","author":"Shapiro","year":"2003","journal-title":"Minerva Ginecol."},{"key":"10.1016\/j.gyobfe.2005.06.011_bib27","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1093\/humrep\/deg407","article-title":"GnRH antagonists followed by a decline in serum estradiol results in adverse outcomes in donor oocyte cycles","volume":"18","author":"Lindheim","year":"2003","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.gyobfe.2005.06.011_bib28","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0015-0282(00)01766-0","article-title":"Metformin treatment of patients with polycystic ovary syndrome undergoing in vitro fertilization improves outcomes and is associated with modulation of the insulin-like growth factors","volume":"75","author":"Stadtmauer","year":"2001","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.gyobfe.2005.06.011_bib29","first-page":"42","article-title":"Metformin treatment before IVF\/ICSI in PCOS women: A prospective, randomized, double-blind study","volume":"18","author":"Kjotrod","year":"2003","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.gyobfe.2005.06.011_bib30","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1093\/humrep\/14.3.683","article-title":"Revival of the natural cycles in in vitro fertilization with the use of a new gonadotrophin-releasing hormone antagonist (Cetrorelix): a pilot study with minimal stimulation","volume":"14","author":"Rongi\u00e8res-Bertrand","year":"1999","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.gyobfe.2005.06.011_bib31","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.fertnstert.2004.03.055","article-title":"Reducing the dose of human chorionic gonadotropin in high responders does not affect the outcomes of in vitro fertilization","volume":"82","author":"Schmidt","year":"2004","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.gyobfe.2005.06.011_bib32","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0301-2115(00)00539-X","article-title":"Combined approach as an effective method in the prevention of severe ovarian hyperstimulation syndrome","volume":"97","author":"Isik","year":"2001","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.gyobfe.2005.06.011_bib33","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0015-0282(16)58404-0","article-title":"Triggering of ovulation with a GnRH agonist in patient pretreated with a GnRH antagonist: a pilot study","volume":"66","author":"Olivennes","year":"1996","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.gyobfe.2005.06.011_bib34","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1093\/humrep\/15.9.1965","volume":"15","author":"Itskovitz-Eldor","year":"2000","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.gyobfe.2005.06.011_bib35","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/humupd\/4.2.103","article-title":"Maturation in vitro of immature human oocytes for clinical use","volume":"4","author":"Cha","year":"1998","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.gyobfe.2005.06.011_bib36","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1093\/oxfordjournals.humrep.a135867","article-title":"Prolonged coasting: an effective method for preventing severe ovarian hyperstimulation syndrome in patients undergoing in-vitro fertilization","volume":"10","author":"Sher","year":"1995","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.gyobfe.2005.06.011_bib37","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1093\/humrep\/deh298","article-title":"Coasting acts through downregulation of VEGF gene expression and protein secretion","volume":"19","author":"Garcia-Velasco","year":"2004","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.gyobfe.2005.06.011_bib38","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S0015-0282(98)00280-5","article-title":"Prevention of severe ovarian hyperstimulation by coasting","volume":"70","author":"Dhont","year":"1998","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.gyobfe.2005.06.011_bib39","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1093\/humrep\/14.6.1421","article-title":"Timed early unilateral follicular aspiration compared with coasting for prevention of severe ovarian hyperstimulation syndrome\u00a0: a prospective randomized study","volume":"14","author":"Egbase","year":"1999","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.gyobfe.2005.06.011_bib40","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1093\/humrep\/17.5.1217","article-title":"Value of measuring serum FSH in addition to serum estradiol in a coasting programme to prevent severe OHSS","volume":"17","author":"Al-Shawaf","year":"2002","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.gyobfe.2005.06.011_bib41","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.fertnstert.2003.12.041","article-title":"Predictors of success during the coasting period in high-responder patients undergoing controlled ovarian stimulation for assisted conception","volume":"82","author":"Ulug","year":"2004","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.gyobfe.2005.06.011_bib42","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1093\/humrep\/14.2.294","article-title":"High pregnancy rates and successful prevention of severe ovarian hyperstimulation syndrome by prolonged coasting of very hyperstimulated patients\u00a0: a multicentre study","volume":"14","author":"Waldenstr\u00f6m","year":"1999","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.gyobfe.2005.06.011_bib43","unstructured":"Moreno L, Diaz I, Pacheco A, Zuniga A, Requena A, Garcia-Velasco JA. Extended coasting duration exerts a negative impact on IVF cycle outcome due to premature luteinization."},{"key":"10.1016\/j.gyobfe.2005.06.011_bib44","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0015-0282(03)00548-X","article-title":"Comparison of coasting and intravenous albumin in the prevention of ovarian hyperstimulation syndrome","volume":"80","author":"Chen","year":"2003","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.gyobfe.2005.06.011_bib45","first-page":"25","article-title":"Oocyte quality and IVF outcome after coasting to prevent ovarian hyperstimulation syndrome","volume":"48","author":"Delvigne","year":"2003","journal-title":"Int. J. Fertil. Womens Med."},{"key":"10.1016\/j.gyobfe.2005.06.011_bib46","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1093\/humrep\/17.7.1777","article-title":"Oocyte and embryo quality after coasting: the experience from oocyte donation","volume":"17","author":"Isaza","year":"2002","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.gyobfe.2005.06.011_bib47","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S0015-0282(97)00560-8","article-title":"\u201cCoasting\u201d does not adversely affect cycle outcome in a subset of highly responsive in vitro fertilization patients","volume":"69","author":"Tortoriello","year":"1998","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.gyobfe.2005.06.011_bib48","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/S0015-0282(97)81373-8","article-title":"Withholding gonadotropin administration is an effective alternative for the prevention of ovarian hyperstimulation syndrome","volume":"67","author":"Benadiva","year":"1997","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.gyobfe.2005.06.011_bib49","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/humrep\/16.1.24","article-title":"Prevention of severe ovarian hyperstimulation syndrome in IVF with or without ICSI and embryo transfer: a modified \u201c coasting \u201d strategy based on ultrasound for identification of high-risk patients","volume":"16","author":"Al-Shawaf","year":"2001","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.gyobfe.2005.06.011_bib50","article-title":"\u00ab\u00a0Coasting\u00a0\u00bb (withholding gonadotrophins) for perventing ovarian hyperstimulation syndrome","volume":"3","author":"D\u2019Angelo","year":"2002","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.gyobfe.2005.06.011_bib51","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0015-0282(97)81517-8","article-title":"Intravenous albumin does not prevent the development of severe ovarian hyperstimulation syndrome","volume":"68","author":"Chen","year":"1997","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.gyobfe.2005.06.011_bib52","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1093\/oxfordjournals.humrep.a138185","article-title":"The use of intravenous albumin in patients at high risk for severe ovarian hyperstimulation syndrome","volume":"8","author":"Asch","year":"1993","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.gyobfe.2005.06.011_bib53","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1093\/humrep\/12.7.1573","article-title":"Cryopreservation of all prezygotes in patients at risk of severe hyperstimulation does not eliminate the syndrome, but the chances of pregnancy are excellent with subsequent frozen-thaw transfers","volume":"12","author":"Queenan","year":"1997","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.gyobfe.2005.06.011_bib54","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0015-0282(02)03290-9","article-title":"Administration of methylprednisolone to prevent severe ovarian hyperstimulation syndrome in patients undergoing in vitro fertilization","volume":"78","author":"Lainas","year":"2002","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.gyobfe.2005.06.011_bib55","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1093\/humrep\/13.5.1157","article-title":"Does withholding gonadotropin administration prevent severe ovarian hyperstimulation syndrome?","volume":"13","author":"Lee","year":"1998","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.gyobfe.2005.06.011_bib56","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0015-0282(98)00438-5","article-title":"Withholding gonadotropins to minimize the risk of ovarian hyperstimulation during superovulation and in vitro fertilization embryo transfer cycles","volume":"71","author":"Fluker","year":"1999","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.gyobfe.2005.06.011_bib57","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1479-828X.2004.00226.x","article-title":"Effects of coasting on the oycome of intracytoplasmic sperm injection-embryo transfer cycles","volume":"44","author":"Aktan","year":"2004","journal-title":"Aust N Z Obstet Gynaecol"}],"container-title":["Gyn\u00e9cologie Obst\u00e9trique & Fertilit\u00e9"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297958905002146?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297958905002146?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T17:26:29Z","timestamp":1548177989000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297958905002146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9]]},"references-count":57,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["S1297958905002146"],"URL":"https:\/\/doi.org\/10.1016\/j.gyobfe.2005.06.011","relation":{},"ISSN":["1297-9589"],"issn-type":[{"value":"1297-9589","type":"print"}],"subject":[],"published":{"date-parts":[[2005,9]]}}}